ANL
Adlai Nortye Ltd. American Depositary Shares
NASDAQ: ANL · HEALTHCARE · BIOTECHNOLOGY
$14.27
+1.28% today
Updated 2026-04-30
Market cap
$953.09M
P/E ratio
—
P/S ratio
190.62x
EPS (TTM)
$-1.11
Dividend yield
—
52W range
$1 – $17
Volume
0.4M
Adlai Nortye Ltd. American Depositary Shares (ANL) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | $45.73M | $0.00 | $5.00M | $0.00 | $5.00M |
| Revenue growth (YoY) | — | — | — | -100.0% | — | -100.0% | — |
| Cost of revenue | $1.48M | $1.51M | — | $2.04M | $2.22M | $1.87M | — |
| Gross profit | $-1.48M | $-1.51M | $45.73M | $-2.04M | $5.00M | $-1.87M | $5.00M |
| Gross margin | — | — | 100.0% | — | 100.1% | — | 100.0% |
| R&D | $13.34M | $19.04M | $42.10M | $54.49M | $58.15M | $44.91M | $32.83M |
| SG&A | — | $6.52M | $12.45M | $12.43M | $14.82M | $9.44M | $7.79M |
| Operating income | $-19.12M | $-26.10M | $-8.65M | $-67.27M | $-72.55M | $-52.93M | $-35.70M |
| Operating margin | — | — | -18.9% | — | -1452.3% | — | -714.0% |
| EBITDA | $-15.88M | $-60.12M | $-53.58M | $-56.32M | $-106.22M | $-48.05M | $-32.63M |
| EBITDA margin | — | — | -117.2% | — | -2126.1% | — | -652.5% |
| EBIT | $-17.36M | $-61.63M | $-55.41M | $-58.36M | $-108.44M | $-49.92M | $-34.04M |
| Interest expense | $466145.00 | $1.75M | $1.34M | $433000.00 | $791000.00 | $1.94M | $1.49M |
| Income tax | $-1.00 | $3.00 | $-46.19M | $8.31M | $643000.00 | — | — |
| Effective tax rate | 0.0% | -0.0% | 44.9% | -16.5% | -0.6% | 0.0% | 0.0% |
| Net income | $-17.83M | $-63.38M | $-56.68M | $-58.79M | $-109.23M | $-51.87M | $-35.53M |
| Net income growth (YoY) | — | -255.5% | +10.6% | -3.7% | -85.8% | +52.5% | +31.5% |
| Profit margin | — | — | -124.0% | — | -2186.5% | — | -710.6% |